Cover Image
市場調查報告書

非侵入性血糖監測儀

Bloodless Glucose Monitors

出版商 Greystone Research Associates 商品編碼 345953
出版日期 內容資訊 英文
商品交期: 最快1-2個工作天內
價格
Back to Top
非侵入性血糖監測儀 Bloodless Glucose Monitors
出版日期: 2015年12月02日 內容資訊: 英文
簡介

小型的電子產品與具高度生物相容性的產品設計的融合,創造糖尿病和確診患者的非侵入性血糖監測儀的光明前景。

本報告提供非侵入性血糖監測儀的技術與市場相關調查、糖尿病患者及糖尿病管理相關概要、非侵入性血糖監測儀的開發及商業化的各種配合措施、各種實行技術與新興技術概要、市場成長的各種影響因素及相關法律分析、主要地區與國家研究計劃,以及主要企業的簡介等彙整。

目錄

  • 摘要整理
  • 糖尿病管理市場推動因素
  • 人口統計
  • 管理護理
  • 全球影響
  • 糖尿病管理:2020年的展望
  • 血糖值的監測
  • 病人依從性的主要因素
  • 產業的合作/競爭環境
  • 非侵入性監測設計因素
  • 組織間液的檢測
  • 校準和可靠性
  • 準確度、正確
  • 靈敏度
  • 檢測頻率
  • 資料回收、報告
  • 患者/用戶界面
  • 實行技術、新興技術
  • 感應技術
  • 信號處理電子產品
  • 模式認識
  • 自我輸出型感測器
  • 非侵入式血糖檢測儀:短期
  • 光譜學為基礎的監測
  • 螢光
  • 水凝膠矩陣
  • 多模式感測為基礎的監測
  • 超音波/導電性/熱容
  • 經皮血糖檢測
  • 接眼血糖檢測
  • 生物標記檢測
  • 無線穿戴式鏡片
  • 呼氣分析
  • 唾液檢驗
  • 淚液分析
  • 拋棄式試劑
  • 組織光強度檢測
  • 市場影響因素
  • 法律規章
    • FDA
    • EMEA
    • 日本
  • 研究計劃
    • 北美
    • 歐洲
    • 以色列
    • 日本
  • 企業簡介
目錄
Product Code: BGM293T

Patient-centric Syringe & Injector Design

The convergence of small-scale electronics and sophisticated biocompatible product designs is creating the prospect of bloodless glucose monitoring for patients diagnosed with diabetes. Bloodless glucose monitors that can measure glucose levels accurately and reliably have the capability to improve glycemic control and patient wellbeing. By integrating the sensing element, electronics, and a power source in a single package, noninvasive monitors are creating new options for caregivers and their diabetes patients. Signal processing improvements - include improved signal-to-noise ratios and interference filtering - will continue to be critical to the commercialization prospects of noninvasive monitors. While the potential is substantial, for most participants the road to commercialization will be rocky due to capitalization requirements and the need for investor patience. Successful players will be those that can form partnerships and strategic alliances

What You Will Learn

  • What are the bloodless monitoring technologies and devices that are moving toward commercialization and that are expected to have an impact on the diabetes management market by the end of the decade?
  • What are the products currently under development, and what is their current status in terms of market readiness and product validation?
  • What are the signification product development and commercialization issues facing the current generation of bloodless glucose monitors?
  • Who are the companies behind bloodless glucose monitors, what are their capabilities and risk factors and what are their key supply chain issues?
  • What are the commercialization prospects of the bloodless glucose monitors?
  • What are the significant market factors that will impact the market for bloodless glucose monitors?

Market-driven Product Strategies

A longer life span is expected to translate to a growing number of patients diagnosed with chronic conditions. To counteract the financial and medical infrastructure implications of this trend, pressure from the public sector and managed care organizations will place a premium on therapeutic self-administration, an expectation that is creating an increased interest in routes of administration that are patient-friendly and cost-effective. Pharma company decision makers have come to the realization that for many products, success no longer only depends on the medication itself but also on achieving a consumer-compatible form of packaging and application.

‘Traditional monitoring and insulin administration techniques require diabetes patients to carry glucose testing and insulin administration paraphernalia with them when they leave home and to prick themselves numerous times during the course of the day. These activities are seen as restrictive and socially and physically uncomfortable by most insulin-dependent diabetics, and can result in less-than-optimal compliance in management schedules. For adolescent patients, aversion to needle sticks is a real issue that must be dealt with by children and parents.'

Our reports are carefully researched and written to provide timely and insightful analysis of key factors and developments shaping the commercial marketplace. The focused nature of our publications is designed to allow readers to identify emerging demand and growth opportunities in selected markets. Numerous charts, tables and graphs complement the text, with evaluations and assessments of current and probable future market developments, technology issues and business factors - information necessary to compete effectively in the global marketplace.

Table of Contents

Executive Summary

  • Diabetes Management Market Drivers
  • Demographics
  • Managed Care
  • Global Impact
  • Diabetes Management - A View to 2020
  • Monitoring Glucose Levels
  • Key Factors in Patient Compliance
  • Industry Alignment/Competitive Landscape
  • Noninvasive Monitor Design Factors
  • Measuring Interstitial Fluid
  • Calibration & Reliability
  • Accuracy & Precision
  • Sensitivity
  • Measurement Frequency
  • Data Collection & Reporting
  • Patient/User Interface
  • Enabling & Emerging Technologies
  • Sensor Technology
  • Signal Processing Electronics
  • Pattern Recognition
  • Self-Powered Sensors
  • Noninvasive Glucose Monitors -The Near Term
  • Monitors based on Spectroscopy
  • Fluorescence
  • Hydrogel Matrices
  • Monitors based on Multimode Sensing
  • Ultrasonic/Conductivity/Heat Capacity
  • Transdermal Glucose Measurement
  • Ocular Glucose measurement
  • Biomarker Measurement
  • Wireless Wearable Lens
  • Breath Analysis
  • Saliva Analysis
  • Tears Analysis
  • Disposable Reagent
  • Tissue Photometry
  • Market Factors
  • Regulations
  • FDA
  • EMEA
  • Japan
  • Research Programs
  • North America
  • Europe
  • Israel
  • Japan

Company Profiles

Back to Top